Welcome to our dedicated page for Butterfly Network SEC filings (Ticker: BFLY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Butterfly Network, Inc. (NYSE: BFLY) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including current reports on Form 8-K and other documents filed with the U.S. Securities and Exchange Commission. These filings give investors and analysts detailed insight into Butterfly’s financial reporting, corporate actions and material events related to its handheld ultrasound devices, Ultrasound-on-Chip™ semiconductor technology and digital health software platforms.
Recent Form 8-K filings for BFLY cover several key topics. Some 8-Ks furnish press releases announcing quarterly financial results and preliminary revenue expectations, along with business updates on AI initiatives, chip development milestones and enterprise software such as Compass™ and Compass AI™. Other 8-Ks describe executive leadership changes, including the appointment of a new Chief Financial Officer and related compensation and severance arrangements for finance executives.
Butterfly’s filings also document material agreements. For example, an 8-K dated November 17, 2025 describes a Co-Development and Licensing Agreement with Midjourney, Inc., under which Butterfly grants an exclusive, non-transferable license within a specified field of use to certain Ultrasound-on-Chip technology, software and backend technology, in exchange for specified fees, milestone payments, revenue sharing and chip-related payments. This type of filing helps readers understand how Butterfly’s semiconductor platform is being licensed to partners.
Another notable 8-K, dated January 13, 2026, reports that the New York Stock Exchange has determined to commence proceedings to delist Butterfly’s public warrants (ticker BFLY WS) and suspend trading in those warrants due to "abnormally low selling price" levels under NYSE rules. The filing states that this action does not affect trading in Butterfly’s Class A common stock, which continues on the NYSE under the symbol BFLY.
On Stock Titan, these SEC documents are supplemented with AI-powered summaries that highlight the main points of each filing, helping readers quickly understand topics such as results of operations, material contracts, leadership changes and listing status. Users can review Forms 8-K for event-driven updates, and refer to annual and quarterly reports (Forms 10-K and 10-Q) for broader financial and operational details as they become available through the SEC’s EDGAR system.
BFLY filing reports an affiliate sale notification for Class A shares. The notice lists 42,540 Class A shares connected to a restricted stock vesting on 03/02/2026 and records a proposed sale under that vesting event.
The filing also discloses that Steven Cashman sold 250,000 Class A shares on 02/26/2026 for 1087050.30. The filing is a routine Form 144 notice of proposed sale by an affiliate.
Butterfly Network Chief Business Officer Steve Cashman reported an open-market sale of 250,000 shares of Class A common stock. The sale occurred at a weighted average price of $4.348 per share, with individual prices between $3.99 and $4.955, under a Rule 10b5-1 trading plan. After this transaction, he holds 1,931,884 shares directly.
Butterfly Network, Inc. reports 2025 annual results, highlighting growth in its handheld ultrasound and software platform. Revenue rose to $97.6 million from $82.1 million in 2024, driven by its Ultrasound‑on‑Chip™ devices, enterprise software, and emerging home-care and veterinary offerings.
The company remains unprofitable, posting a net loss of $77.1 million, and continues to invest in AI tools, global expansion and its Butterfly Embedded™ co‑development program. Butterfly had about 220 employees as of January 31, 2026 and sells in over 30 countries, positioning its technology as a lower-cost alternative to traditional cart-based ultrasound.
Butterfly Network, Inc. reported strong fourth quarter 2025 results, highlighted by record quarterly revenue of $31.5 million, up 41% from $22.4 million a year earlier, and its first quarter of positive operating cash flow with net cash inflow of $6.3 million.
U.S. revenue grew to $26.8 million, a 55% increase, helped by $6.8 million from a new Midjourney co-development partnership, while international revenue was $4.7 million. GAAP gross margin improved to 67.3%, driven by high-margin Butterfly Embedded licensing and lower software amortization.
Net loss narrowed to $15.3 million from $18.1 million, and adjusted EBITDA loss improved to $3.2 million from $9.1 million. Cash and cash equivalents reached $150.5 million as of December 31, 2025. For 2026, the company guides to revenue of $117–$121 million, implying about 20–24% growth, and an adjusted EBITDA loss of $21–$25 million.
Butterfly Network, Inc. received an amended Schedule 13D/A from Glenview Capital entities and Larry Robbins updating their ownership and warrant status. Glenview Capital Management, LLC reports beneficial ownership of 14,335,055 shares of Class A common stock, representing 6.34% of the class. Larry Robbins reports beneficial ownership of 19,268,892 shares, or 8.52% of the class, including stock options and unvested restricted stock units tied to his service on the board. The amendment also notes that private placement warrants held by Glenview funds and Longview Investors LLC expired on February 12, 2026, unexercised and for no value.
Butterfly Network, Inc. received an updated ownership report showing that Fosun Industrial Co., Limited and its parent Shanghai Fosun Pharmaceutical (Group) Co., Ltd. together beneficially own 10,716,630 shares of Butterfly’s Class A common stock, representing 4.7% of the class as of December 31, 2025.
The filing states all 10,716,630 shares are held by Fosun Industrial, with both Fosun entities sharing voting and dispositive power. The 4.7% figure is calculated against 226,175,175 Class A shares outstanding as of October 21, 2025, and the investors certify the stake is held on a passive basis, not to influence control.